CASALE, Maddalena
 Distribuzione geografica
Continente #
NA - Nord America 1.356
EU - Europa 1.337
AS - Asia 275
AF - Africa 2
Totale 2.970
Nazione #
US - Stati Uniti d'America 1.349
IE - Irlanda 498
IT - Italia 319
GB - Regno Unito 145
SG - Singapore 124
DE - Germania 118
CN - Cina 109
UA - Ucraina 91
GR - Grecia 45
SE - Svezia 30
FR - Francia 29
FI - Finlandia 22
TR - Turchia 19
BE - Belgio 13
PK - Pakistan 8
CA - Canada 7
CH - Svizzera 7
NL - Olanda 5
CZ - Repubblica Ceca 4
HK - Hong Kong 3
AT - Austria 2
ID - Indonesia 2
IN - India 2
KR - Corea 2
MK - Macedonia 2
BG - Bulgaria 1
CY - Cipro 1
ET - Etiopia 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
LU - Lussemburgo 1
MD - Moldavia 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
RU - Federazione Russa 1
SC - Seychelles 1
TH - Thailandia 1
TW - Taiwan 1
Totale 2.970
Città #
Dublin 486
Chandler 231
Jacksonville 188
Santa Clara 164
Singapore 92
Ann Arbor 88
Bremen 70
Princeton 70
Caserta 69
Roxbury 66
Medford 51
Beijing 43
New York 38
Woodbridge 35
Wilmington 25
Nanjing 24
Naples 23
Des Moines 22
Boardman 21
Ashburn 19
Cambridge 19
Grumo Nevano 17
Napoli 16
Brussels 13
Munich 12
San Mateo 9
Helsinki 8
Pozzuoli 8
Rome 8
Nanchang 7
Nocera Inferiore 7
Redwood City 7
Fairfield 6
Mountain View 6
Elora 5
Istanbul 5
Kunming 5
Milan 5
Orlando 5
San Sebastiano al Vesuvio 5
Stella Cilento 5
Auburn Hills 4
Brno 4
Changchun 4
Lappeenranta 4
Pagani 4
Seattle 4
Tianjin 4
Casoria 3
Eboli 3
Florence 3
Gunzenhausen 3
Hong Kong 3
Houston 3
Jinan 3
London 3
Norwalk 3
Rio Saliceto 3
Shanghai 3
Shenyang 3
Bandung 2
Bitola 2
Caggiano 2
Carpi 2
Den Haag 2
Dolo 2
Lanzhou 2
Leawood 2
Lissone 2
Los Angeles 2
Messina 2
Oxford 2
Padova 2
Parma 2
Rimini 2
Salerno 2
San Giorgio A Cremano 2
Seoul 2
Altavilla Irpina 1
Amsterdam 1
Atlanta 1
Aversa 1
Bangkok 1
Belgrade 1
Berlin 1
Bologna 1
Briceni 1
Cagliari 1
Casorzo 1
Catanzaro 1
Cava de' Tirreni 1
Chengdu 1
Deventer 1
Genoa 1
Giugliano In Campania 1
Glendale 1
Hanover 1
Hefei 1
Imola 1
Izmir 1
Totale 2.125
Nome #
Cognitive, Brain and Intracranial Artery Involvement in Beta Thalassemia 119
HNF-1β mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred. 89
Effects of germline VHL deficiency on growth, metabolism, and mitochondria 88
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano mutation) 77
Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major. 75
Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload 75
Congenital erythrocytosis associated with gain-of-function HIF2A gene mutations and erythropoietin levels in the normal range. 73
National systematic approach to the management of asplenia: the set up of the Italian Network on Asplenia 64
Long-term improvement in cardiac magnetic resonance in β-thalassemia major patients treated with deferasirox extends to patients with abnormal baseline cardiac function 61
Congenital Dyserythropoietic Anemia Type II: molecular analysis and expression of the SEC23B Gene. 61
Asymptomatic intracranial aneurysms in beta-thalassemia: A three-year follow-up report 60
Blood transfusions and adverse acute events: a retrospective study from 214 transfusion-dependent pediatric patients comparing transfused blood components by apheresis or by whole blood 57
Deferasirox: la chelazione ottimale nelle anemie trasfusione-dipendenti 53
Long-term efficacy of deferasirox for cardiac siderosis in thalassemia major 53
Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major 52
Splenectomy for hereditary spherocytosis: complete, partial or not at all? 52
A Novel 12q13.2-q13.3 Microdeletion Syndrome With Combined Features of Diamond Blackfan Anemia, Pierre Robin Sequence and Klippel Feil Deformity 52
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 51
Brain iron content in systemic iron overload: A beta-thalassemia quantitative MRI study 51
Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience 51
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned 51
Long term efficacy of iron chelation therapy with deferasirox on endocrine function in thalassemia major 50
Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients 48
Cb2 receptor stimulation and dexamethasone restore the anti-inflammatory and immune-regulatory properties of mesenchymal stromal cells of children with immune thrombocytopenia 48
Longitudinal Prospective MRI Study in Pediatric Patients With Thalassemia Major 47
BONE MINERAL DENSITY IMPROVEMENT IN PATIENTS WITH THALASSEMIA MAJOR ON LONG-TERM CHELATION THERAPY WITH DEFERASIROX 46
Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis 46
Access to emergency department for acute events and identification of sickle cell disease in refugees. 46
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective 46
Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multicentre nation-wide cohort 46
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study 45
Brain functional impairment in beta-thalassaemia: the cognitive profile in Italian neurologically asymptomatic adult patients in comparison to the reported literature 45
Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia 43
No evidence of increased cerebrovascular involvement in adult neurologically-asymptomatic β-Thalassaemia. A multicentre multimodal magnetic resonance study 43
Mutations in ANKRD26 are responsible for a frequent form of inherited thrombocytopenia: Analysis of 78 patients from 21 families 41
Association of immune thrombocytopenia and celiac disease in children: A retrospective case control study 40
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters 39
Life-Threatening Drug-Induced Liver Injury in a Patient with β-Thalassemia Major and Severe Iron Overload on Polypharmacy. 39
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey. 38
Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP) 38
Red blood cell alloimmunisation in transfusion-dependent thalassaemia: A systematic review 38
Headache in beta-thalassemia: An Italian multicenter clinical, conventional MRI and MR-angiography case-control study 37
Rubrica a cura di luciano de seta quando il saturimetro mente… 36
Prospective MRI study in pediatric thalassemia major (TM) patients in the MIOT network: a tool to strengthen medical decisions 35
Hb Vanvitelli: A new unstable α-globin chain variant causes undiagnosed chronic haemolytic anaemia when co-inherited with deletion − α3.7. 35
Clinical and molecular spectrum of glucose-6-phosphate isomerase deficiency. Report of 12 new cases 34
Tricuspid-valve regurgitant jet velocity as a risk factor for death in β-Thalassemia. 34
Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up 33
Myocardial fibrosis by CMR LGE in a large cohort of pediatric thalassemia major patients 33
Italian patients with hemoglobinopathies exhibit a 5-fold increase in age-standardized lethality due to SARS-CoV-2 infection 33
Subarachnoid haemorrhage and cerebral vasculopathy in a child with sickle cell anaemia 32
White matter volume changes in adult beta-thalassemia: Negligible and unrelated to anemia and cognitive performances 32
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major 30
Nineteen-month-old girl with persistent fever 30
Familial neurohypophyseal diabetes insipidus in 13 kindreds and 2 novel mutations in the vasopressin gene 30
No increased cerebrovascular involvement in adult beta-thalassemia by advanced MRI analyses 30
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 30
Management of the risk for severe infections in children with asplenia: Recommendations from the Italian Network of Asplenia 28
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation 26
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority 26
Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE) for the Management of Endocrine Complications in Patients with Haemoglobinopathies 26
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network 21
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 21
Will the changing therapeutic landscape meet the needs of patients with sickle cell disease? 20
Selecting β-thalassemia Patients for Gene Therapy: A Decision-making Algorithm 20
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy 20
[The Management of Endocrine Complications in Patients with Haemoglobinopathies: Good Clinical Practice of the Italian Society of Thalassemia and Haemoglobinopathies (SITE).] 19
Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values 19
Response to measles, mumps and rubella (Mmr) vaccine in transfusion-dependent patients 18
Thalassaemia is paradoxically associated with a reduced risk of in-hospital complications and mortality in COVID-19: Data from an international registry 18
Mortality in β-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization 17
Incidence of cancer and related deaths in hemoglobinopathies: A follow-up of 4631 patients between 1970 and 2021 13
Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology 13
Absence of blood donors’ anti-SARS-CoV-2 antibodies in pre-storage leukoreduced red blood cell units indicates no role of passive immunity for blood recipients 11
Childhood Multiple Endocrine Neoplasia (MEN) Syndromes: Genetics, Clinical Heterogeneity and Modifying Genes 11
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study 9
Reply to "Hepatocellular carcinoma in thalassemia and other hemoglobinopathies" 9
Inflammatory and senescence-associated mediators affect the persistence of humoral response to COVID-19 mRNA vaccination in transfusion-dependent beta-thalassemic patients 8
Transient erythroblastopenia of childhood after COVID-19 infection: a case report 8
Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose 8
Early splenectomy in sickle cell disease: another piece of the puzzle 6
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey 4
Totale 3.160
Categoria #
all - tutte 16.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 0 0 0 41 17 62 12 47 12 47 8
2020/2021290 17 5 20 34 33 13 58 18 9 28 50 5
2021/2022465 14 0 7 9 125 31 40 21 23 21 35 139
2022/2023974 103 26 28 60 129 77 0 52 454 10 19 16
2023/2024356 30 14 14 18 132 39 2 10 4 3 28 62
2024/2025283 10 10 10 44 209 0 0 0 0 0 0 0
Totale 3.160